Physician profile

Mark J Wild

Internal Medicine · Bel Air, MD

NPI 1679578207

$6,338.15

in general payments reported to CMS, 2019-2025

30 companies · $1,439 in 2025

The $1,439 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,655.00
Education$124.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $1,551.53 2019-2025 Breztri, Farxiga, Airsupra
Novo Nordisk INC $720.01 2019-2025 Rybelsus, Ozempic
Pfizer INC. $635.27 2019-2025
Amgen INC. $482.14 2019-2025 Evenity, Otezla, Repatha
Lilly USA, LLC $462.29 2022-2025 Mounjaro, Zepbound, Jardiance
Abbvie INC. $461.62 2019-2025 Synthroid, Ubrelvy, Vraylar
Amarin Pharma, INC. $371.34 2019-2022
Boehringer Ingelheim Pharmaceuticals, INC. $278.70 2019-2025 Jardiance, Synjardy
Exact Sciences Corporation $240.40 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Astellas Pharma US INC $189.62 2019-2024 Veozah
Merck Sharp & Dohme LLC $185.03 2019-2025 Capvaxive, Gardasil 9, Gardasil
Glaxosmithkline, LLC. $129.72 2023-2024 Trelegy Ellipta, Shingrix, Arexvy
Biohaven Pharmaceutical Holding Company Ltd. $99.02 2022
Phathom Pharmaceuticals, INC. $67.58 2024-2025 Voquezna
Sumitomo Pharma America, INC. $64.38 2024-2025 Gemtesa
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Bayer Healthcare Pharmaceuticals INC. $57.55 2025
Medtronic, INC. $44.91 2021-2025 Closurefast
Dynavax Technologies Corporation $33.97 2023-2024 Heplisav-B
Curonix LLC $31.68 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Sanofi Pasteur INC. $31.28 2019-2020
Kowa Pharmaceuticals America, INC. $30.97 2020-2021
Tanabe Pharma America, INC. $29.77 2019
Collegium Pharmaceutical, INC. $23.97 2025 Belbuca
Genentech USA, INC. $20.74 2021
Irhythm Technologies, INC. $19.02 2024 Zio Xt Patch, Zio Monitor
Axsome Therapeutics, INC. $17.92 2023 Sunosi
E.R. Squibb & Sons, L.L.C. $16.06 2022
Allergan, INC. $15.37 2019
Arbor Pharmaceuticals, INC. $14.84 2020
Tms Neurohealth Centers INC. $11.45 2025 Tms Neurohealth Centers INC.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark J Wild

$6,338.15

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals Lp
Context
The $1,439 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/76165/mark-j-wild

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.